Market Size (2015)
2015
$1.05B
Vertical: HealthcareBase Year: 201711 Sections
Market Size (2015)
2015
$1.05B
Projected (2023)
2023
$1.46B
CAGR (2015–2023)
4.2%
4.2%Key Players
109+
This report covers Vaginal Slings Market with forecasts from 2015 to 2023. 109 key companies are profiled.
The Vaginal Slings Market market is projected to grow at a CAGR of 4.2% from 2015 to 2023.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe vaginal sling is the procedure that is highly recommended for surgical treatments of stress urinary incontinence. The mid-urethral sling is considered as the gold standard method that has replaced all conventional procedures as it is efficient, safe, and requires minimal recovery time (30 to 45 minutes). Factors such as increasing cases of urinary incontinence along with the growing investment by leading market players and healthcare providers boosted the market growth in the near future
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Process
Market Research Future analysis is based on interviews with industry experts who offer insight into the market structure, market segmentation, technology assessment, competitive landscape (CL), market penetration, as well as the emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and the current market position. Furthermore, the varying trends in segments and categories in each region are studied and estimated based on primary and secondary research.
Primary Research
Extensive primary research was conducted to gain a deeper insight into the market and industry performance. For this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, marketing directors, and business development managers, among others) of the major players active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed in the next five to 10 years.
Secondary Research
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global vaginal slings market. It was also used to obtain key information about major players, market classification and segmentation according to industry trends, and developments related to the market and technology. For this study, analysts have gathered information from various credible sources such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, and paid databases.
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of the overall global vaginal slings market. The key players in the market were identified through secondary research, and their market contributions in different applications across the globe were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Market Research Future added before being presented in this report. The following figure shows an illustrative representation of the overall market size estimation process employed for this study.
Base Year
2017
Historical Period
2015 – 2017
Forecast Period
2017 – 2023
Primary Interviews
150+
Historical data (2015–2017) and forecast period (2017–2023)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansBargaining Power of Suppliers
The bargaining power of suppliers in the vaginal slings market is low to medium. In this market, the suppliers are manufacturers of surgical devices, medical implant, and consumable & accessories. There are many major and small manufacturers are providing vaginal slings. The number of suppliers serving the vaginal slings market is equal in the number of buyer’s in the sector. The supplier concentration is low to moderate in the vaginal slings market.
On the other hand, since the high and specific quality of the material is used for manufacturing urinary incontinence device, only a moderate number of viable raw material substitutes are available, which further boosts the bargaining power of suppliers in the market. In addition, low chances of forwarding integration decrease the bargaining power of suppliers
Most of the key players are divesting enormous money from this product category as there are many lawsuits filed by the customers. Strong brands have been discontinued their products decreasing the brand value in the market while many medium and small players are also providing the same products at different pricing. The ancient market of products is affecting the bargaining power of suppliers.
Bargaining Power of Buyers
The bargaining power of the buyer in vaginal slings is low. Bargaining power of the buyer can define by how easily the buyer can get the products. Currently, the market has a low number of buyers due to the various complications exhibited by the sling surgery. The buyers comprise of clinics, hospitals, urology clinics, and individual healthcare professionals. The presence of buyers in the market is low due to lack of interest by the population, and a high rate of complications in the treatment of urology diseases.
Also, buyers are price sensitive, which moderately affects their bargaining power in the market. There is a presence of a high number of device manufacturers in the world, which provides products at low cost. Also, switching cost is low for buyers as many alternative devices are available in the market which is cost-effective and available.
Threat of New Entrants
The threat of new entrants in the vaginal slings market is considered to have a low impact on the market. The vaginal slings market is a specialized market with high potential and requiring high technological knowledge. The vaginal slings market is also very sensitive to technological advancements and disruptive innovations. Advancement of any novel vaginal sling device with even a small benefit over existing products will have a terrible effect on the existing players.
Moreover, the numerous allegations on the key players have led to losing market share. Large capital requires for the development of product may decrease the threat of new entrants in the global vaginal slings market. Thus, the above factors affect the entry of new players moderately.
Threat of Substitutes
The threat of substitutes in the global vaginal slings market is high. Any threat from a close substitute product is measured to have a high impact on the market. The threat from the substitutes arises when the buyers or the customers in the market can accomplish the end-result using other similar product. Vaginal slings procedure have alternatives in the form of a transvaginal mesh, injectable bulking agents, and retropubic colposuspension. Substitutes are the various types of treatment devices itself, which completely depends on the type of surgery. In addition, the low degree of switching cost and safety maximize the threat of substitutes.
Intensity of Rivalry
The intensity of rivalry in the global vaginal slings market is low. The strength of competitive rivalry evaluates the ability and the level of rivalry among competitors in the market. Many leading and minor companies are competing with each other and putting pressure which eventually leads to minimize the profit. Vaginal slings device manufacturing companies are discontinuing their product line due to several lawsuits being filed in developed regions due to increased complications and side effects in women. Also, brand loyalty has been affected that led to the loss of market share for the key players. The competitors are withdrawing and selling their product category for liquidation and lowering their losses.
Market estimates by geography (2023)
InsightEurope leads with $409.00M by 2023, while South America is projected to grow fastest at a 4.5% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2015 | 2017 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $117.20M | $142.20M | $158.50M | 3.8% | 11% |
| North America | $286.50M | $348.20M | $404.90M | 4.4% | 28% |
| Asia Pacific | $261.50M | $319.80M | $361.90M | 4.1% | 25% |
| Europe | $292.90M | $360.80M | $409.00M | 4.3% | 28% |
| South America | $88.00M | $104.10M | $124.70M | 4.5% | 9% |
| Total | $1.05B | $1.28B | $1.46B | 4.2% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.46B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Retropubic Method | $597.10M | 4.2% | 88% |
| Transobturator Method | $479.80M | 4.2% | 81% |
| Single-Incision Mini Method | $382.00M | 4.2% | 87% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Vaginal Slings Market covering market dynamics, competitive landscape, and strategic outlook.
The Vaginal Slings Market market is projected to reach $1.46B by 2023, growing at 4.2% CAGR. The Retropubic Method segment holds the largest share.
Vaginal sling procedures have witnessed an increase in demand owing to the rise in preference for the treatment of urinary incontinence. Women suffering from severe urinary incontinence lose bladder control and experience urine leakage after coughing or sneezing that affects the patients daily life, so they are advised to undergo vaginal sling surgeries.
Due to the rise in the number of women experiencing urinary incontinence, especially stress urinary incontinence across the globe is set to propel the market growth. Thus, soaring female geriatric population boosts market growth. Moreover, an increase in developments pertaining to materials utilized in constructing advanced vaginal slings supplements the growth of the market. Moreover, increase in the technological advancements regarding vaginal slings offer profitable opportunities for the expansion of the market.
Urinary incontinence is a significant medical issue with extensive social and financial effect. Also, in young women, the predominance of incontinence is generally low. However, it peaks around menopause, with an enduring rise there-after into later life. Urinary incontinence is more common in women than in men. This condition has been on the rise globally due to factors such as age, family history, and lower urinary tract symptoms. Several chronic diseases, such as diabetes and neurological diseases (multiple sclerosis and Parkinson's disease) can also lead to urinary incontinence.
As per the National Association for Incontinence, stress urinary incontinence is the most prevalent form of incontinence among women which affects nearly 15 million adult women in the US in 2017. Pregnancy, childbirth, and menopause are major reasons for the increased prevalence of incontinence in women as compared to men which in turn has led to the growth of the global vaginal slings market. The worldwide increase of the incidence of urinary incontinence has resulted in the high adoption rate of vaginal or urinary sling procedures to address urinary incontinence. Thus, with the global increase in the number of urinary incontinence cases, the treatment procedures such as vaginal sling surgeries are increasing.
Further, the incontinence might be a consequence of bladder dysfunction, sphincter dysfunction, or a combination of both, yet extensive studies are not intended to decide the etiology. In women, moderate and severe incontinence both have a prevalence range of about 3% to 17%. Severe incontinence has a low prevalence in young women, but this rate rapidly increases at the age between 70 and 80 years. Stress incontinence accounts for less than 10% of cases and is attributable to prostate surgery, trauma, or neurological injury. Thus, with the growing prevalence rate of urinary incontinence, the market is expected to show additional growth.
Medical tourism initiatives taken up by governments have played a major role in the growth of the health care sector globally. The key treatment areas of focus for medical tourism include cancer (often high-acuity or last resort) and cardiovascular and bladder disorders (including urinary incontinence). These initiatives have allowed people globally to seek for treatment solutions while considering various factors such as cost, quality, and downtime of the procedure.
Cost is a significant factor contributing to the growth of medical tourism. The hospitals and clinics present in countries such as India offer vaginal sling procedures at much lower costs than the developed countries, prompting patients to seek treatment here. This leads to an increase in revenue and volume of these procedures in these countries.
Various surgeries are performed for the treatment of urinary incontinence, but with these treatments, various complications arise. For example, urethral sling surgery, likewise called mid-urethral sling surgery, is done to treat urinary incontinence. A sling is set around the urethra to lift it back into a normal position and to apply weight on the urethra to help pee maintenance. The sling is connected to the stomach (belly) wall. The common complications associated with slings include urinary tract infections, hemorrhage or wound hematoma, and overactive bladder.
According to the study conducted by the International Continence Society in 2013, the postoperative wound infections are reported to occur in approximately 12% of sling procedures and are more frequent with autologous fascia. However, in the review published by the American Urological Association a much lower rate of wound infection with sling procedures was reported (nearly 0.1%). The wound infection rate was similar among autologous, homologous and synthetic slings.
In assessing the long-term clinical value of a technique both long-term and short-term complications should be assessed, as conventional continence procedures have well-documented complications. Immediate complications include hemorrhage, urinary tract and visceral injuries, and urinary tract infection. Short-term problems include wound infection, osteitis pubis, nerve injuries, and voiding dysfunction. Long-term complications include bladder overactivity, stitch/ sling erosion, dyspareunia, and genital prolapse. Thus, with the following complication after the surgery, some patients may hesitate to take the treatment, and thus this factor will hinder the growth of the global vaginal slings market.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 109 companies operating in the Vaginal Slings Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
Promedon
Company Headquarters: Cordoba, Argentina Founded: 1985 Company Working: Promedon is a leading company in the research, development, production, and distribution of innovative medical technology products. The company has a presence in more than 60 countries around the world. It is a leading company in the distribution of arthroscopy and arthroplasty solutions in Argentina and Chile, and an important player in the distribution of spine, neurosurgery and reconstructive surgery solutions in the Argentine, Brazilian and Chilean markets.
Herniamesh S.r.l.
Company Headquarters: Chivasso, Italy Company Working: Herniamesh S.r.l. has a worldwide distribution network. The company is involved in the production and marketing of medical devices for hernioplasties well as for the treatment of the dysfunctions in the pelvic floor, urinary incontinence, and pressure ulcers. The products of the company are distributed worldwide.
Dipromed Srl
Company Headquarters: Italy Founded: 1978 Company Working: Dipromed Srl is an Italian company involved in the manufacturing of medical devices. The company specializes in manufacturing surgical mesh, urogynecological prosthetic system, urologic prosthetic system, and in vitro diagnostic devices (IVD). The company has a wide distribution channel.
CL Medical
Company Headquarters: France Founded: 2002 Company Working: CL Medical is involved in the design and development of single-use medical and surgical devices. The company offers I-STOP, a sub-urethral treatment of female stress urinary incontinence. The company is based in Sainte Foy Les Lyon, France.
Caldera Medical
Company Headquarters: Agoura Hills, California, US Founded: 2002 Company Working: Caldera Medical is a medical device company focused on minimally invasive applications for improving women’s health. The company operates in urogynecology, gynecology, and urology clinical specialties. The company develops and markets surgical implants, specifically for the treatment of stress urinary incontinence and pelvic organ prolapse. Moreover, the company also focuses on different initiatives to improve women’s health such as surgeon training, patient education, and several humanitarian aid programs.
Betatech Medical
Company Headquarters: Basaksehir, Istanbul Founded: 1974 Company Working: Betatech Medical is involved in the design, research, production, and sales of surgical products. The company designs and manufactures devices used in spine surgery, neurosurgery, gynecology, urology, and abdominal surgery. The company has a global presence in more than 30 countries.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Vaginal Slings Market